Langen KJ - Search Results

1

Integrated boost IMRT with FET-PET-adapted local dose escalation in glioblastomas. Results of a prospective phase II study.

Piroth MD, Pinkawa M, Holy R, Klotz J, Schaar S, Stoffels G, Galldiks N, Coenen HH, Kaiser HJ, Langen KJ, Eble MJ. Piroth MD, et al. Among authors: langen kj. Strahlenther Onkol. 2012 Apr;188(4):334-9. doi: 10.1007/s00066-011-0060-5. Epub 2012 Feb 22. Strahlenther Onkol. 2012. PMID: 22349712 Clinical Trial.

2

Applications of PET imaging of neurological tumors with radiolabeled amino acids.

Galldiks N, Langen KJ. Galldiks N, et al. Among authors: langen kj. Q J Nucl Med Mol Imaging. 2015 Mar;59(1):70-82. Epub 2014 Dec 17. Q J Nucl Med Mol Imaging. 2015. PMID: 25517079 Review.

3

Evaluation of new 18F-labeled amino acids for brain PET.

Langen KJ, Hamacher K, Pauleit D, Floeth FW, Stoffels G, Bauer D, Reifenberger G, Zilles K, Coenen HH. Langen KJ, et al. Anat Embryol (Berl). 2005 Dec;210(5-6):455-61. doi: 10.1007/s00429-005-0033-5. Anat Embryol (Berl). 2005. PMID: 16177907 No abstract available.

4

Transport mechanisms of 3-[123I]iodo-alpha-methyl-L-tyrosine in a human glioma cell line: comparison with [3H]methyl]-L-methionine.

Langen KJ, Mühlensiepen H, Holschbach M, Hautzel H, Jansen P, Coenen HH. Langen KJ, et al. J Nucl Med. 2000 Jul;41(7):1250-5. J Nucl Med. 2000. PMID: 10914918 Free article.

5

O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.

Weckesser M, Langen KJ, Rickert CH, Kloska S, Straeter R, Hamacher K, Kurlemann G, Wassmann H, Coenen HH, Schober O. Weckesser M, et al. Among authors: langen kj. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):422-9. doi: 10.1007/s00259-004-1705-8. Epub 2005 Jan 14. Eur J Nucl Med Mol Imaging. 2005. PMID: 15650870 Clinical Trial.

6

Quantification of the whole-body distribution of PET radiopharmaceuticals, applied to 3-N-([18F]fluoroethyl)spiperone.

Herzog H, Coenen HH, Kuwert T, Langen KJ, Feinendegen LE. Herzog H, et al. Among authors: langen kj. Eur J Nucl Med. 1990;16(2):77-83. doi: 10.1007/BF01465913. Eur J Nucl Med. 1990. PMID: 2311622

7

Multimodal target point assessment for stereotactic biopsy in children with diffuse bithalamic astrocytomas.

Messing-Jünger AM, Floeth FW, Pauleit D, Reifenberger G, Willing R, Gärtner J, Coenen HH, Langen KJ. Messing-Jünger AM, et al. Among authors: langen kj. Childs Nerv Syst. 2002 Aug;18(8):445-9. doi: 10.1007/s00381-002-0644-6. Epub 2002 Jul 26. Childs Nerv Syst. 2002. PMID: 12192504

8

3-[123I]Iodo-alpha-methyl-L-tyrosine uptake in cerebral gliomas: relationship to histological grading and prognosis.

Schmidt D, Gottwald U, Langen KJ, Weber F, Hertel A, Floeth F, Felsberg J, Reifenberger G, Coenen HH, Müller-Gärtner HW. Schmidt D, et al. Among authors: langen kj. Eur J Nucl Med. 2001 Jul;28(7):855-61. doi: 10.1007/s002590100553. Eur J Nucl Med. 2001. PMID: 11504082

9

Brain and brain tumor uptake of L-3-[123I]iodo-alpha-methyl tyrosine: competition with natural L-amino acids.

Langen KJ, Roosen N, Coenen HH, Kuikka JT, Kuwert T, Herzog H, Stöcklin G, Feinendegen LE. Langen KJ, et al. J Nucl Med. 1991 Jun;32(6):1225-9. J Nucl Med. 1991. PMID: 2045937 Free article.

10

Whole-body kinetics and dosimetry of L-3--123I-iodo-alpha-methyltyrosine.

Schmidt D, Langen KJ, Herzog H, Wirths J, Holschbach M, Kiwit JC, Ziemons K, Coenen HH, Müller-Gärtner H. Schmidt D, et al. Among authors: langen kj. Eur J Nucl Med. 1997 Sep;24(9):1162-6. doi: 10.1007/BF01254250. Eur J Nucl Med. 1997. PMID: 9283111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

331 results

Search Page

Filters